{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:07:45Z","timestamp":1792800465770,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T00:00:00Z","timestamp":1594339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T00:00:00Z","timestamp":1594339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Khalifa Bin Zayed Al Nahyan Foundation \u2013 Abu Dhabi \u2013 United Arab Emirates","id":[{"id":"https:\/\/ror.org\/007abrq43","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The COVID-19 pandemic has caused a global health crisis. Numerous cancer patients from non-Western countries, including the United Arab Emirates (UAE), seek cancer care outside their home countries and many are sponsored by their governments for treatment. Many patients interrupted their cancer treatment abruptly and so returned to their home countries with unique challenges. In this review we will discuss practical challenges and recommendations for all cancer patients returning to their home countries from treatment abroad.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>Experts from medical, surgical and other cancer subspecialties in the UAE were invited to form a taskforce to address challenges and propose recommendations for patients returning home from abroad after medical tourism during the SARS-COV-19 Pandemic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The taskforce which consisted of experts from medical oncology, hematology, surgical oncology, radiation oncology, pathology, radiology and palliative care summarized the current challenges and suggested a practical approaches to address these specific challenges to improve the returning cancer patients care.<\/jats:p>\n                    <jats:p>Lack of medical documentation, pathology specimens and radiology images are one of the major limitations on the continuation of the cancer care for returning patients. Difference in approaches and treatment recommendations between the existing treating oncologists abroad and receiving oncologists in the UAE regarding the optimal management which can be addressed by early and empathic communications with patients and by engaging the previous treating oncologists in treatment planning based on the available resources and expertise in the UAE. Interruption of curative radiotherapy (RT) schedules which can potentially increase risk of treatment failure has been a major challenge, RT dose-compensation calculation should be considered in these circumstances.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The importance of a thorough clinical handover cannot be overstated and regulatory bodies are needed to prevent what can be considered unethical procedure towards returning cancer patients with lack of an effective handover. Clear communication is paramount to gain the trust of returning patients and their families. This pandemic may also serve as an opportunity to encourage patients to receive treatment locally in their home country. Future studies will be needed to address the steps to retain cancer patients in the UAE rather than seeking cancer treatment abroad.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-020-07115-6","type":"journal-article","created":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T03:03:42Z","timestamp":1594350222000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Challenges for cancer patients returning home during SARS-COV-19 pandemic after medical tourism - a consensus report by the emirates oncology task force"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3819-0500","authenticated-orcid":false,"given":"Humaid O.","family":"Al-Shamsi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Abu-Gheida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabeeha K.","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Nijhawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed S.","family":"Abdulsamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadir","family":"Alrawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abuhaleeqa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taleb M.","family":"Almansoori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thamir","family":"Alkasab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Essa M.","family":"Aleassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine C.","family":"McManus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,10]]},"reference":[{"key":"7115_CR1","doi-asserted-by":"crossref","unstructured":"Al-Shamsi HO, Alhazzani W, Alhuraiji A, Coomes EA, Chemaly RF, Almuhanna M, Wolff R, Nuhad IK, Chua MLK, Hotte SJ, et al. A practical approach to the Management of Cancer Patients during the novel coronavirus disease 2019 (COVID-19) pandemic: an international collaborative group. Oncologist. 2020.","DOI":"10.1634\/theoncologist.2020-0213"},{"key":"7115_CR2","unstructured":"https:\/\/www.worldometers.info\/coronavirus\/, Accessed June 18th 2020."},{"key":"7115_CR3","doi-asserted-by":"crossref","unstructured":"Fauci AS, Lane HC, Redfield RR. Covid-19 - navigating the uncharted. N Engl J Med. 2020.","DOI":"10.1056\/NEJMe2002387"},{"key":"7115_CR4","doi-asserted-by":"publisher","DOI":"10.1101\/2020.02.22.20025320","volume-title":"SARS-CoV-2 transmission in cancer patients of a tertiary hospital in Wuhan","author":"J Yu","year":"2020","unstructured":"Yu J, Ouyang W, Chua M, Xie C. SARS-CoV-2 transmission in cancer patients of a tertiary hospital in Wuhan; 2020. https:\/\/doi.org\/10.1101\/2020.02.22.20025320."},{"key":"7115_CR5","unstructured":"COVID 19 - MOHAP - LATEST INFORMATION & UPDATES, https:\/\/www.mohap.gov.ae\/en\/AwarenessCenter\/Pages\/COVID19-Information-Center.aspx, Accessed June 17th 2020."},{"key":"7115_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tourman.2012.05.009","volume-title":"Contemporary medical tourism: conceptualisation, culture and commodification , Tourism Management","author":"J Connell","year":"2013","unstructured":"Connell J. Contemporary medical tourism: conceptualisation, culture and commodification , Tourism Management, vol. 34; 2013. p. 1\u201313. https:\/\/doi.org\/10.1016\/j.tourman.2012.05.009."},{"issue":"8","key":"7115_CR7","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1093\/jjco\/hyz061","volume":"49","author":"N Awano","year":"2019","unstructured":"Awano N, Takamoto T, Kawakami J, Genda A, Ninomiya A, Ikeda M, Matsuno F, Izumo T, Kunitoh H. Issues associated with medical tourism for cancer care in Japan. Jpn J Clin Oncol. 2019;49(8):708\u201313.","journal-title":"Jpn J Clin Oncol"},{"key":"7115_CR8","volume-title":"The State of Cancer Care in the United Arab Emirates in 2020: Challenges and Recommendations, A report by the United Arab Emirates Oncology Task Force, Issue No. 32","author":"HO Al-Shamis","year":"2020","unstructured":"Al-Shamis HO, Jaffar H , Tirmazy SH et al, The State of Cancer Care in the United Arab Emirates in 2020: Challenges and Recommendations, A report by the United Arab Emirates Oncology Task Force, Issue No. 32 2020, http:\/\/www.gffcc.org\/journal\/issue32.html, Accessed April 27th 2020."},{"key":"7115_CR9","first-page":"1","volume":"4","author":"HO Al-Shamsi","year":"2018","unstructured":"Al-Shamsi HO, Al-Hajeili M, Alrawi S. Chasing the cure around the globe: medical tourism for Cancer care from developing countries. J Global Oncol. 2018;4:1\u20133.","journal-title":"J Global Oncol"},{"issue":"4","key":"7115_CR10","first-page":"12","volume":"49","author":"I Blair","year":"2013","unstructured":"Blair I, Sharif A. Health and health systems performance in the United Arab Emirates. World Hospitals Health Serv. 2013;49(4):12\u20137.","journal-title":"World Hospitals Health Serv"},{"key":"7115_CR11","first-page":"1","volume":"4","author":"DJ Benedetti","year":"2018","unstructured":"Benedetti DJ, Golshan M, Kesselheim JC. Going the distance: ethical issues arising when patients seek Cancer care from international settings. J Global Oncol. 2018;4:1\u20134.","journal-title":"J Global Oncol"},{"issue":"7","key":"7115_CR12","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s12032-020-01382-w","volume":"37","author":"V Jindal","year":"2020","unstructured":"Jindal V, Sahu KK, Gaikazian S, Siddiqui AD, Jaiyesimi I. Cancer treatment during COVID-19 pandemic. Med Oncol. 2020;37(7):58.","journal-title":"Med Oncol"},{"key":"7115_CR13","doi-asserted-by":"crossref","unstructured":"Schrag D, Hershman DL, Basch E. Oncology practice during the COVID-19 pandemic. JAMA. 2020.","DOI":"10.1001\/jama.2020.6236"},{"key":"7115_CR14","doi-asserted-by":"publisher","first-page":"102439","DOI":"10.1016\/j.bcmd.2020.102439","volume":"83","author":"KK Sahu","year":"2020","unstructured":"Sahu KK, Jindal V, Siddiqui AD, Cerny J. Facing COVID-19 in the hematopoietic cell transplant setting: A new challenge for transplantation physicians. Blood Cells Mol Dis. 2020;83:102439.","journal-title":"Blood Cells Mol Dis"},{"key":"7115_CR15","unstructured":"Coronavirus Disease Covid-19: EBMT recommendations (update may 18, 2020), https:\/\/www.ebmt.org\/ebmt\/documents\/coronavirus-disease-covid-19-ebmt-recommendations-update-may-18-2020\n, Accessed June 18th 2020."},{"issue":"2","key":"7115_CR16","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.transci.2018.04.018","volume":"57","author":"SK Toprak","year":"2018","unstructured":"Toprak SK. Donor lymphocyte infusion in myeloid disorders. Transfus Apher Sci. 2018;57(2):178\u201386.","journal-title":"Transfus Apher Sci"},{"issue":"4","key":"7115_CR17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.clml.2019.11.019","volume":"20","author":"F Kerbage","year":"2020","unstructured":"Kerbage F, Sakr R, Lapierre V, Alexandrova K, Coman T, Leroux S, Lucas N, Pilorge S, Solary E, Bourhis JH, et al. Donor lymphocyte infusions after allogeneic transplantation: a single-center experience. Clin Lymphoma Myeloma Leuk. 2020;20(4):209\u201311.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"7115_CR18","doi-asserted-by":"crossref","unstructured":"Kothari S, Artz AS, Lee SM, Fulton N, Park JH, Stock W, Larson RA, Odenike O, Kline J, LaBelle J, et al. Dose escalation prophylactic donor lymphocyte infusion after T-cell depleted matched related donor allogeneic hematopoietic cell transplantation is feasible and results in higher donor chimerism, faster immune re-constitution, and prolonged progression-free survival. Bone Marrow Transplant. 2020.","DOI":"10.1038\/s41409-020-0798-4"},{"key":"7115_CR19","doi-asserted-by":"crossref","unstructured":"Shapiro RM, Antin JH. Therapeutic options for steroid-refractory acute and chronic GVHD: an evolving landscape. Expert Rev Hematol. 2020:1\u201314.","DOI":"10.1080\/17474086.2020.1752175"},{"issue":"1","key":"7115_CR20","doi-asserted-by":"publisher","first-page":"84","DOI":"10.5114\/ceji.2018.75831","volume":"44","author":"G Afram","year":"2019","unstructured":"Afram G, Watz E, Remberger M, Nygell UA, Sundin M, Hagglund H, Mattsson J, Uhlin M. Higher response rates in patients with severe chronic skin graft-versus-host disease treated with extracorporeal photopheresis. Cent Eur J Immunol. 2019;44(1):84\u201391.","journal-title":"Cent Eur J Immunol"},{"issue":"12","key":"7115_CR21","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.clml.2019.09.619","volume":"19","author":"SG Kodad","year":"2019","unstructured":"Kodad SG, Sutherland H, Limvorapitak W, Abou Mourad Y, Barnett MJ, Forrest D, Gerrie A, Hogge DE, Nantel SH, Narayanan S, et al. Outpatient autologous stem cell transplants for multiple myeloma: analysis of safety and outcomes in a tertiary care center. Clin Lymphoma Myeloma Leuk. 2019;19(12):784\u201390.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"3","key":"7115_CR22","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s11899-017-0382-1","volume":"12","author":"U Zahid","year":"2017","unstructured":"Zahid U, Akbar F, Amaraneni A, Husnain M, Chan O, Riaz IB, McBride A, Iftikhar A, Anwer F. A review of autologous stem cell transplantation in lymphoma. Curr Hematol Malig Reports. 2017;12(3):217\u201326.","journal-title":"Curr Hematol Malig Reports"},{"key":"7115_CR23","doi-asserted-by":"crossref","unstructured":"Mannelli C. Whose life to save? Scarce resources allocation in the COVID-19 outbreak. J Med Ethics. 2020.","DOI":"10.1136\/medethics-2020-106227"},{"key":"7115_CR24","first-page":"1","volume":"4","author":"F Elias","year":"2018","unstructured":"Elias F, Bou-Orm IR, Adib SM, Gebran S, Gebran A, Ammar W. Cost of oncology drugs in the middle-eastern country of Lebanon: an update (2014-2016). J Global Oncol. 2018;4:1\u20137.","journal-title":"J Global Oncol"},{"key":"7115_CR25","doi-asserted-by":"publisher","unstructured":"AIO Y. Management of blood supply and demand during the COVID-19 pandemic in King Abdullah Hospital, Bisha, Saudi Arabia [published online ahead of print, 2020 Jun 4]. Transfus Apher Sci. 2020:102836. https:\/\/doi.org\/10.1016\/j.transci.2020.102836.","DOI":"10.1016\/j.transci.2020.102836"},{"key":"7115_CR26","unstructured":"Coronavirus (COVID-19) Update: FDA Provides Updated Guidance to Address the Urgent Need for Blood During the Pandemic, https:\/\/www.fda.gov\/news-events\/press-announcements\/coronavirus-covid-19-update-fda-provides-updated-guidance-address-urgent-need-blood-during-pandemic , Accessed June 18th 2020."},{"key":"7115_CR27","unstructured":"Dhiman Y, Patidar GK, Arora S. Covid-19 pandemic- response to challenges by blood transfusion services in India: a review report. ISBT Science Series. n\/a(n\/a)."},{"key":"7115_CR28","unstructured":"Zaineb Al Hassani, Dubai blood shortage woes were expected, https:\/\/www.thenational.ae\/uae\/dubai-blood-shortage-woes-were-expected-1.379218 Accessed June 18th 2020."},{"key":"7115_CR29","unstructured":"How you can donate blood in the UAE, Huda Tabrez, https:\/\/gulfnews.com\/living-in-uae\/health\/how-you-can-donate-blood-in-the-uae-1.1592324968701?slide=5, Accessed June 18th 2020."},{"issue":"3","key":"7115_CR30","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1001\/jamaoncol.2015.4508","volume":"2","author":"RJ Bleicher","year":"2016","unstructured":"Bleicher RJ, Ruth K, Sigurdson ER, Beck JR, Ross E, Wong YN, Patel SA, Boraas M, Chang EI, Topham NS, et al. Time to surgery and breast Cancer survival in the United States. JAMA Oncol. 2016;2(3):330\u20139.","journal-title":"JAMA Oncol"},{"issue":"3","key":"7115_CR31","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1001\/jamaoncol.2015.3856","volume":"2","author":"M Chavez-MacGregor","year":"2016","unstructured":"Chavez-MacGregor M, Clarke CA, Lichtensztajn DY, Giordano SH. Delayed initiation of adjuvant chemotherapy among patients with breast Cancer. JAMA Oncol. 2016;2(3):322\u20139.","journal-title":"JAMA Oncol"},{"key":"7115_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijsu.2018.09.013","volume":"59","author":"Q Qin","year":"2018","unstructured":"Qin Q, Xu H, Liu J, Zhang C, Xu L, Di X, Zhang X, Sun X. Does timing of esophagectomy following neoadjuvant chemoradiation affect outcomes? A meta-analysis. Int J Surg. 2018;59:11\u20138.","journal-title":"Int J Surg"},{"issue":"3","key":"7115_CR33","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.athoracsur.2019.09.076","volume":"109","author":"JD Rice","year":"2020","unstructured":"Rice JD, Heidel J, Trivedi JR, van Berkel VH. Optimal surgical timing after Neoadjuvant therapy for stage IIIa non-small cell lung Cancer. Ann Thorac Surg. 2020;109(3):842\u20137.","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"7115_CR34","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/bjh.12724","volume":"165","author":"S Kuipers","year":"2014","unstructured":"Kuipers S, Venemans A, Middeldorp S, Buller HR, Cannegieter SC, Rosendaal FR. The risk of venous thrombosis after air travel: contribution of clinical risk factors. Br J Haematol. 2014;165(3):412\u20133.","journal-title":"Br J Haematol"},{"key":"7115_CR35","unstructured":"Cancer. In: Gelband H, Jha P, Sankaranarayanan R, Horton S, editors. Disease Control Priorities. 3rd, 3 ed. Washington (DC); 2015."},{"issue":"4","key":"7115_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30149-2","volume":"21","author":"H Wang","year":"2020","unstructured":"Wang H, Zhang L. Risk of COVID-19 for patients with cancer. Lancet Oncol. 2020;21(4):e181.","journal-title":"Lancet Oncol"},{"key":"7115_CR37","unstructured":"Achard V, Tsoutsou P, Zilli T. Radiotherapy in the time of the Coronavirus pandemic: when less is better. Int J Radiat Oncol Biol Phys. 2020."},{"key":"7115_CR38","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ctro.2020.03.009","volume":"22","author":"R Simcock","year":"2020","unstructured":"Simcock R, Thomas TV, Estes C, Filippi AR, Katz MA, Pereira IJ, Saeed H. COVID-19: global radiation oncology's targeted response for pandemic preparedness. Clin Transl Radiat Oncol. 2020;22:55\u201368.","journal-title":"Clin Transl Radiat Oncol"},{"key":"7115_CR39","doi-asserted-by":"crossref","unstructured":"Zaorsky NG, Yu JB, McBride SM, Dess RT, Jackson WC, Mahal BA, Chen R, Choudhury A, Henry A, Syndikus I, et al. Prostate Cancer radiotherapy recommendations in response to COVID-19. Adv Radiat Oncol. 2020.","DOI":"10.1016\/j.adro.2020.10.003"},{"key":"7115_CR40","unstructured":"Matthias Guckenberger, Claus Belka, Andrea Bezjak, Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement , https:\/\/www.thegreenjournal.com\/article\/S0167-8140(20)30182-1\/pdf, Accessed April 27th 2020."},{"key":"7115_CR41","doi-asserted-by":"crossref","unstructured":"Thomson DJ, Palma D, Guckenberger M, Balermpas P, Beitler JJ, Blanchard P, Brizel D, Budach W, Caudell J, Corry J, et al. Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: an ASTRO-ESTRO consensus statement. Int J Radiat Oncol Biol Phys. 2020.","DOI":"10.1016\/j.radonc.2020.04.019"},{"issue":"4","key":"7115_CR42","doi-asserted-by":"publisher","first-page":"e319","DOI":"10.1200\/JOP.2016.017863","volume":"13","author":"K Thomas","year":"2017","unstructured":"Thomas K, Martin T, Gao A, Ahn C, Wilhelm H, Schwartz DL. Interruptions of head and neck radiotherapy across insured and indigent patient populations. J Oncol Pract. 2017;13(4):e319\u201328.","journal-title":"J Oncol Pract"},{"issue":"14","key":"7115_CR43","first-page":"5653","volume":"15","author":"S Krusun","year":"2014","unstructured":"Krusun S, Pesee M, Supakalin N, Thamronganantasakul K, Supaadirek C, Padoongcharoen P. Treatment interruption during concurrent chemoradiotherapy of uterine cervical cancer; analysis of factors and outcomes. APJCP. 2014;15(14):5653\u20137.","journal-title":"APJCP"},{"key":"7115_CR44","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/1748-717X-7-208","volume":"7","author":"PM Putora","year":"2012","unstructured":"Putora PM, Schmuecking M, Aebersold D, Plasswilm L. Compensability index for compensation radiotherapy after treatment interruptions. Radiat Oncol. 2012;7:208.","journal-title":"Radiat Oncol"},{"issue":"7","key":"7115_CR45","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1634\/theoncologist.11-7-774","volume":"11","author":"MB Lobrano","year":"2006","unstructured":"Lobrano MB. Partnerships in oncology and radiology: the role of radiology in the detection, staging, and follow-up of lung cancer. Oncologist. 2006;11(7):774\u20139.","journal-title":"Oncologist"},{"key":"7115_CR46","doi-asserted-by":"crossref","unstructured":"Liang W, Guan W, Chen R, Wang W, Li J, Xu K, Li C, Ai Q, Lu W, Liang H, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020.","DOI":"10.1016\/S1470-2045(20)30096-6"},{"key":"7115_CR47","unstructured":"Cancer patient management during the covid-19 pandemic https:\/\/www.esmo.org\/guidelines\/cancer-patient-management-during-the-covid-19-pandemic, Accessed April 27th 2020."},{"key":"7115_CR48","unstructured":"COVID-19 Information, https:\/\/www.cap.org\/news\/2020\/latest-on-the-novel-coronavirus-covid-19, College of American Pathologists, Accessed April 27th 2020."},{"issue":"8","key":"7115_CR49","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1056\/NEJMoa1000678","volume":"363","author":"JS Temel","year":"2010","unstructured":"Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363(8):733\u201342.","journal-title":"N Engl J Med"},{"key":"7115_CR50","doi-asserted-by":"publisher","first-page":"714","DOI":"10.14694\/EDBK_175474","volume":"37","author":"CB Smith","year":"2017","unstructured":"Smith CB, Phillips T, Smith TJ. Using the new ASCO clinical practice guideline for palliative care concurrent with oncology care using the TEAM approach. Am Soc Clin Oncol Educ Book. 2017;37:714\u201323.","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"7115_CR51","doi-asserted-by":"publisher","unstructured":"Al-Shamsi HO. Palliative Care in the United Arab Emirates, a desperate need, Aug 20, 2018 - Palliat med care 5(3): 1-4. DOI. https:\/\/doi.org\/10.15226\/2374-8362\/5\/3\/00161.","DOI":"10.15226\/2374-8362\/5\/3\/00161"},{"issue":"11","key":"7115_CR52","doi-asserted-by":"publisher","first-page":"e0206550","DOI":"10.1371\/journal.pone.0206550","volume":"13","author":"M Pettersson","year":"2018","unstructured":"Pettersson M, Hoglund AT, Hedstrom M. Perspectives on the DNR decision process: a survey of nurses and physicians in hematology and oncology. PLoS One. 2018;13(11):e0206550.","journal-title":"PLoS One"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07115-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-020-07115-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07115-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T19:30:08Z","timestamp":1625859008000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-07115-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,10]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["7115"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-07115-6","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,10]]},"assertion":[{"value":"4 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not required for a review article.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Al-Shamsi reports research support from Khalifa Bin Zayed Al Nahyan Foundation \u2013 Abu Dhabi \u2013 United Arab Emirates and Roche Pharmaceuticals Middle East FZCO for research publication of other manuscripts during the conduct of this review study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation or approval of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"641"}}